---
schema_version: "secwatch.filing_event.v1"
accession: "0000816956-26-000101"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2026-07-29T20:10:29+00:00"
generated_at: "2026-07-29T20:12:50.434698+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CONMED Q2 adjusted EPS $1.38 beats; raises FY2026 adjusted EPS guidance to $4.48-$4.60

## Summary
- Q2 sales $343.5M (+0.3% as reported); organic constant currency sales +6.0% excluding GI product exits.
- GAAP EPS $0.77 (+11.6%); adjusted EPS $1.38 (+20.0%), both include $0.21 IEEPA tariff refund benefit.
- Full-year 2026 adjusted EPS guidance raised to $4.48-$4.60 (prior $4.30-$4.45); organic constant currency growth guidance narrowed to 5.0%-6.0%.
- Appointed John E. Gallagher as CFO effective July 15, 2026; added Celine Martin and Jeff Mirviss to Board effective July 1.
- AirSeal Robotic Solution now indicated for use with Intuitive's da Vinci 5 platform (8 mm hex cannulas).

## SEC filing metadata
- accession: 0000816956-26-000101
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2026-07-29T20:10:29+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000081695626000101/0000816956-26-000101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000081695626000101/cnmd-20260729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000816956-26-000101
- JSON: https://secwatch.observer/filing/0000816956-26-000101.json
- Plain text: https://secwatch.observer/filing/0000816956-26-000101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.